108 related articles for article (PubMed ID: 21920619)
1. Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China.
Zeng P; Zhu X; Zhang Y; Wang S; Zhang T
Diabetes Res Clin Pract; 2011 Nov; 94(2):299-304. PubMed ID: 21920619
[TBL] [Abstract][Full Text] [Related]
2. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
[TBL] [Abstract][Full Text] [Related]
3. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.
Cheung BM; Wat NM; Man YB; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Diabetes Care; 2007 Jun; 30(6):1430-6. PubMed ID: 17337491
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
[TBL] [Abstract][Full Text] [Related]
5. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius.
Cameron AJ; Zimmet PZ; Soderberg S; Alberti KG; Sicree R; Tuomilehto J; Chitson P; Shaw JE
Diabet Med; 2007 Dec; 24(12):1460-9. PubMed ID: 17976203
[TBL] [Abstract][Full Text] [Related]
7. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
13. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome according to different definitions in a hypertensive population.
Lioudaki E; Vrentzos GE; Mavrogeni H; Zeniodi MH; Ganotakis ES; Mikhailidis DP; Papadakis JA
Angiology; 2012 Jan; 63(1):39-47. PubMed ID: 21555311
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
17. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study.
Henneman P; Aulchenko YS; Frants RR; van Dijk KW; Oostra BA; van Duijn CM
J Med Genet; 2008 Sep; 45(9):572-7. PubMed ID: 18550697
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese.
Wang J; Li H; Franco OH; Yu Z; Liu Y; Lin X
Obesity (Silver Spring); 2008 Jan; 16(1):172-8. PubMed ID: 18223631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
